"Providence Medford Medical Center is a full-service, 168-bed, acute care, not-for-profit community hospital providing exceptional health care to southern Oregon and northern California. Services offered include emergency services, stroke care, cardiac and vascular care, birth center, total joint replacement and spine health programs, robotic surgery, pain management services, and one of the most comprehensive rehabilitation programs in the region"

During the past decade, Providence Medford Medical Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 13 clinical trials were completed, i.e. on average, 185.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 9 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Providence Medford Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 11 trials, followed by "Radiation Therapy Oncology Group" with 5 trials sponsored, "SWOG Cancer Research Network" with 3 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "GOG Foundation" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Medford Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 12 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Providence Medford Medical Center" are "Breast Cancer" (4 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (4 trials), "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (4 trials), "Breast Adenocarcinoma" (3 trials) and "Prostate Cancer" (3 trials). Many other conditions were trialed in "Providence Medford Medical Center" in a lesser frequency.

Most popular intervention types in "Providence Medford Medical Center" are "Drug" (19 trials), "Other" (18 trials), "Biological" (9 trials), "Radiation" (6 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (12 trials), "Paclitaxel" (7 trials), "Quality-of-Life Assessment" (5 trials), "Cyclophosphamide" (4 trials) and "Doxorubicin Hydrochloride" (4 trials). Other intervention names were less common.

The vast majority of trials in "Providence Medford Medical Center" are 13 trials for "All" genders, 8 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Providence Medford Medical Center". undefined are not yet recruiting, 3 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Providence Medford Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Providence Medford Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Providence Medford Medical Center has several departments that took part in Clinical trials: "Providence Medical Group-Medford Neurology" - 5 trials